Session Name: Poster Session B: Kidney Complications II
Session Type: Poster Session
Date: Sunday, April 30, 2017
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall D1
Background: Acute rejection in HLA matched kidney transplant recipients is uncommon, and the mechanisms involved are not well understood.
Methods: Data from 6 antigen HLA matched patients transplanted between 1994 and 2013 were analyzed to identify the incidence, risk factors, and outcomes associated with biopsy-proven acute rejection.
Results: A total of 278 HLA-matched patients were identified. Ten patients experienced BPAR (0.41 cases per 100 person-years, 95% CI 0.22-0.76). Thirty percent of patients who rejected had graft loss and 10% died compared to 30.8% graft loss and 28.4% death in non-rejectors (p=0.57 and 0.2, respectively). Mean time to rejection was 48.9 months (SD±57.9). Acute cellular (ACR), antibody mediated (AMR), and mixed rejection occurred in 5, 4, and 3 patients, respectively (Table 1). The majority of ACR biopsies were classified as Banff IA (n=5). Nine patients did not have DP matching. Four out of 10 patients had documented non-adherence to maintenance immunosuppression. There was no difference between patients who experienced rejection compared to those who did not based on age, gender, ethnicity, induction agent, PRA, sensitizing events, or infection in the first year of transplant.
|Age at Transplant||Sex||Donor Type||HLA Matching||RejectionType|
|1||71||M||DBD||No DP typing
Possible Allelic Mismatch DR11, 15, DQ3
|2||42||M||LD-S||No DP typing||AMR|
|3||46||F||LD-S||No DP typing||AMR|
|4||38||M||LD-S||No Cw or DP typing
|5||16||M||DBD||No DP typing
Allele Mismatch DR11
|6||23||M||LD-S||No DP typing
|7||61||M||DBD||No Cw or DP typing
Possible Allelic Mismatch at DR4, 11, DQ3
|8||60||F||LD-S||No DP typing||Mixed|
Conclusions: In patients with 6 HLA matched kidneys, ACR was more common than AMR. Non-adherence was apparent in 40% of patients. Acute rejection was not associated with higher graft loss or death. Lacking DP typing for all patients, the pathogenesis of acute rejection in HLA-matched patients remains to be determined.
CITATION INFORMATION: Condon A, Astor B, Holdener K, Ellis T, Djamali A. Acute Rejection in 6 Antigen HLA Matched Kidney Transplant Recipients: Risk Factors and Outcomes. Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:Condon A, Astor B, Holdener K, Ellis T, Djamali A. Acute Rejection in 6 Antigen HLA Matched Kidney Transplant Recipients: Risk Factors and Outcomes. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/acute-rejection-in-6-antigen-hla-matched-kidney-transplant-recipients-risk-factors-and-outcomes/. Accessed June 26, 2022.
« Back to 2017 American Transplant Congress